AUSTIN, Texas--(BUSINESS WIRE)--Biotechnology company Beacon Sciences, LLC, announced today the new product introduction of a diagnostic assay for quantification of creatinine, a urine metabolite and universal indicator of kidney function, that changes color to the naked eye. Unlike existing assays, Beacon has created this assay using a synthetic receptor for this compound that replaces traditional enzyme and antibody based approaches. Many additional compounds can be detected using this proprietary method which ultimately will allow more testing to be done at the point-of-care, physician office lab, and home settings.
